Figure 3 | Scientific Reports

Figure 3

From: Short term survival of critically ill COVID-19 Egyptian patients on assisted ventilation treated by either Dexamethasone or Tocilizumab

Figure 3

Showed Kaplan–Meier survival curve of critically ill COVID-19 patients, (A) for patients who received Toclizumab compared to those received pulse Dexamethasone (P = 0.002). (B) for patients with CT Chest showing Ground glass opacities (GGO) compared with bilateral consolidation, (P < 0.0001). (C) patients who do not need vasopressors at admission and those who need vasopressors at admission (P < 0.0001). (D) patients on mechanical ventilation compared to those on Non-invasive ventilation (P < 0.0001).

Back to article page